A study published in the Journal of the American Medical Association reported that carriers of the CYP2C19 loss-of-function allele face higher risks of cardiovascular death, myocardial infarction, and stroke, particularly for in-stent thrombosis events (12). The gene discussed is CYP2C19; the disease is stroke disorder.